The effectiveness of such a strategy has been shown in cancer treatment (Kieda et al. 2012), where the normalisation of blood vessels by alleviating hypoxia resulting in the phosphatase and tensin homolog (PTEN) activation has been demonstrated to be key in the treatment of hypoxia-related diseases, such as cancer. The gene discussed is PTEN; the disease is cancer.